United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Vivodyne lands $38m to transform drug development with lab-grown human organs Vivodyne, a biotech company focused on developing more effective drugs tested on lab-grown human organs, announced a colossal… byPallavi MadhirajuNovember 24, 2023